Thoracic and lung involvement in Familial Mediterranean fever (FMF)

Clinics in Chest Medicine

Volumn 23, Issue 2, 2002, Pages 505-511

  Lidar, Merav ^a   Pras, Mordechai ^a   Langevitz, Pnina ^a   Livneh, Avi ^a  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; ASTHMA; DIFFERENTIAL DIAGNOSIS; FAMILIAL MEDITERRANEAN FEVER; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; LUNG CARCINOMA; LUNG DISEASE; PATHOGENESIS; PERICARDITIS; PERITONEUM MESOTHELIOMA; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SYMPTOMATOLOGY; THROMBOEMBOLISM; VASCULITIS; THORAX DISEASE;

FAMILIAL MEDITERRANEAN FEVER; HUMAN; LUNG DISEASES; THORACIC DISEASES; HUMANS;

EID: 0035985690     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(01)00002-8     Document Type: Review

References (69)

1. The changing face of Familial Mediterranean fever
2. Familial Mediterranean fever. A survey of 470 cases and review of the literature
3. Familial Mediterranean fever: Clinical and genetic features in Druze Familial Mediterranean fever and in Iraqi Jews: A preliminary study
4. The role of amyloidosis in Familial Mediterranean fever. A population study
5. Colchicine in the prevention and treatment of amyloidosis of Familial Mediterranean fever
6. A controlled trial of colchicine in preventing attacks of Familial Mediterranean fever
7. Non founder mutations in the MEFV gene establish this gene as the cause of Familial Mediterranean fever (FMF)
8. Pyrin/marenostrin mutations in Familial Mediterranean fever
9. A candidate gene for Familial Mediterranean fever
10. Ancient missense mutations in a new member of the RoRet gene family are likely to cause FMF
11. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and survey of 100 American referrals to the National Institutes of Health
12. The hereditary periodic fever syndromes: Molecular analysis of a new family of inflammatory diseases
13. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments
14. A fever gene comes in from the cold
15. The spectrum of Familial Mediterranean fever mutations
16. Common MEFV mutations among Jewish ethnic groups in Israel: High frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state
17. Familial Mediterranean fever gene
18. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD)
19. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever
20. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever
21. Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations
22. Late-onset familial Mediterranean fever (FMF): A subset with distinct clinical, demographic, and molecular genetic characteristics
23. Criteria for the diagnosis of Familial Mediterranean fever
24. Familial paroxysmal polyseroitis. Analysis of 50 cases
25. Attacks of pericarditis as a manifestation of Familial Mediterranean fever
26. Pericardial disease in Familial Mediterranean fever. An echocardiographic study
27. Leukocyte chemotaxis in recurrent polyserositis (Familial Mediterranean fever)
28. MEFV mutation analysis in patients suffering from amyloidosis of Familial Mediterranean fever
29. Recurrent pulmonary atelectasis as a manifestation of Familial Mediterranean fever
30. Familial recurring polyserositis; a disease entity
31. Familial Mediterranean fever with involvement of the lungs
32. Malignant peritoneal mesothelioma occurring in periodic disease: Apropos of a case
33. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients
34. Peritoneal mesothelioma in recurrent familial peritonitis
35. Peritoneal malignant mesothelioma in a patient with recurrent peritonitis
36. Familial Mediterranean fever; high gene frequency among non-Ashkenazi and Ashkenazi Jewish population in Israel
37. Familial Mediterranean fever; analysis of inheritance and current linkage data
38. Dominant inheritance in two families with Familial Mediterranean fever
39. Decreased incidence of asthma in patients with Familial Mediterranean fever
40. Absence of asthma in patients with Familial Mediterranean fever
41. Possible protection against asthma in heterozygotes for Familial Mediterranean fever
42. Mapping of the gene causing familial Mediterranean fever to the short arm of chromosome 16
43. Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus
44. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3
45. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations
46. Increased serum eosinophil cationic protein levels in Familial Mediterranean fever
47. Distinctive cationic proteins of the human eosinophil granule: Major basic protein, eosinophil cationic protein, and eosinophil derived neurotoxin
48. Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: A prospective study
49. Eosinophil cationic protein levels induced sputum correlate with the severity of bronchial asthma
50. Serum eosinophil cationic protein during treatment of asthma in children
51. Effects of colchicines on IgE mediated early and late airway reactions
52. A clinical and immunologic study of colchicines in asthma
53. An evaluation of colchicines as an alternative to inhaled corticosteroids in moderate asthma
54. Failure of colchicines to reduce inhaled triancinolone dose in patients with asthma
55. Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultra-structural, and immunohistochemical studies
56. Amyloid goiter: Report of the clinical, histological and biochemical features of five cases
57. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome
58. Familial Mediterranean fever and amyloidosis
59. Pulmonary amyloidosis. The Mayo clinic experience from 1980 to 1993
60. Pulmonary hypertension and familial Mediterranean fever: A previously unrecognized association
61. Superior vena cava thrombosis and obstructive sleep apnea in a patient with familial Mediterranean fever
62. Inflammation-mediated rheumatic diseases and atherosclerosis
63. Prevalence of ischemic heart disease in patients with familial Mediterranean fever
64. The lung in polyarteritis nodosa. A pathologic study of 10 cases
65. Polyarteritis nodosa and acute interstitial pneumonia
66. Bronchiolitis obliterans associated with polyarteritis nodosa
67. Pulmonary disease with hemorrhage in Henoch-Schoenlein purpura
68. Pulmonary hemorrhage: An often fatal complication of Henoch-Schoenlein purpura
69. Increased prevalence of Behcet's disease (BD) in familial Mediterranean fever